نتایج جستجو برای: metronomic chemotherapy

تعداد نتایج: 114478  

Journal: :Neuro-oncology 2007
Santosh Kesari David Schiff Lisa Doherty Debra C Gigas Tracy T Batchelor Alona Muzikansky Alison O'Neill Jan Drappatz Alice S Chen-Plotkin Naren Ramakrishna Stephanie E Weiss Brenda Levy Joanna Bradshaw Jean Kracher Andrea Laforme Peter McL Black Judah Folkman Mark Kieran Patrick Y Wen

Preclinical evidence suggests that continuous low-dose daily (metronomic) chemotherapy may inhibit tumor endothelial cell proliferation (angiogenesis) and prevent tumor growth. This phase II study evaluated the feasibility of this antiangiogenic chemotherapy regimen in adults with recurrent malignant gliomas. The regimen consisted of low-dose etoposide (35 mg/m2 [maximum, 100 mg/day] daily for ...

Journal: :iranian journal of blood and cancer 0
amal halim

background: the aim of this study was to investigate the efficacy and safety of metronomic capecitabine chemotherapy in pretreated elderly patients with advanced gastric carsonoma. patients and methods: eligible patients were treated with capecitabine at a fixed dose of 1000mg daily until disease progression or toxicity. endpoints were overall response rate, safety, progression-free survival an...

Journal: :Oncology 2005
Clifford A Hudis

The improved survival associated with adding the anti-vascular endothelial growth factor (VEGF) monoclonal antibody bevacizumab (Avastin) to chemotherapy for the treatment of patients with metastatic colorectal cancer demonstrates the importance of targeting collateral cells involved in tumor growth, progression, and metastatic spread. Based on the Gompertzian model of tumor growth, adding anti...

2013
KAYOKO KIBATA TAKESHI TAMAKI NORIKO INAGAKI MAKOTO OGATA TOSHIKI SHIMIZU SHOSAKU NOMURA

Docetaxel is a well-known causative agent of nail alterations. The aim of this study was to reveal the impact of nail alterations associated with low-dose metronomic (LDM) docetaxel chemotherapy on the survival of non-small cell lung cancer (NSCLC) patients. Clinical information, survival data and nail alterations in patients treated with LDM docetaxel chemotherapy (docetaxel 15 mg/m2 per week)...

2016
Joo Young Jung Geundoo Jang Hunho Song Hyeong Su Kim Dae Ro Choi Jung Hye Kwon Ho Young Kim Boram Han Jung Han Kim Hyo Jung Kim Dae Young Zang

Metronomic chemotherapy is an emerging strategy offering a potentially less toxic yet effective treatment modality. We evaluated the efficacy and safety of low-dose metronomic (LDM) chemotherapy in relapsed or refractory non-Hodgkin lymphoma (NHL) by retrospectively reviewing the data of 16 NHL patients who were treated with oral cyclophosphamide plus methotrexate (CM) as LDM chemotherapy. The ...

Journal: :Breast care 2016
Marcus Schmidt

Despite the advancement of targeted therapies in metastatic breast cancer, chemotherapy is still of pivotal importance. The concept of dose density is known to increase the efficacy of chemotherapy. In metastatic disease, preservation of the quality of life is equally important. Because of this, weekly regimens are a cornerstone in metastatic disease. Taxanes like paclitaxel or nab-paclitaxel a...

2013
Christina Hackl Shan Man Giulio Francia Chloe Milsom Ping Xu Robert S Kerbel

OBJECTIVE Advanced and recurrent diseases are the major causes of death in colon cancer. No standard preclinical model addresses advanced disease and spontaneous metastasis after orthotopic tumour growth. In this study, the authors report the establishment of such standardised orthotopic mouse models of colon cancer and their use in evaluating metronomic topotecan alone or in combination with s...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید